Global Rx Market Will Grow 6%-7% In 2004, Roche Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
The company expects its own performance will surpass the market growth rate.
You may also be interested in...
Average Sales Price Reimbursement Not Affecting Roche Yet
Roche has not seen any change in market dynamics for its products following the switch to an average sales price-based reimbursement model for Medicare Part B drugs
Medicare Reaffirms Faith In Formulary Review Process Ahead Of Part D Changes
Dramatic transformation in the US Medicare Part D benefit design does not require any changes to CMS’ overall approach to reviewing formulary submissions from private drug plan sponsors, the agency says in its final guidance implementing the design changes for 2025.